Yan's study found that compared with patients with HBV+ cirrhosis, patients with HBV+HCC had a significantly lower proportion of CD3+ and CD8+ T cells and an increased proportion of Tregs in their peripheral blood, which means that HBV+HCC exhibits a stronger immune‐suppressive response. The gene discussed is CD8A; the disease is hepatocellular carcinoma.